ESR1 and endometrium adenocarcinoma: Although previous study has shown no effect on Pak1 expression after estrogen treatment in Ishikawa cells (a well-differentiated endometrial adenocarcinoma cell line) [12], we found ERα and ER target gene PR, was reduced after knockdown of Pak1 in RL95-2.